To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question

To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question

Bibliographic Details
Main Author:	Behnood Bikdeli
Format:	Article
Language:	English
Published:	Elsevier 2022-05-01
Series:	Research and Practice in Thrombosis and Haemostasis
Online Access:	https://doi.org/10.1002/rth2.12738

Similar Items

Dose Escalation Trial of Desulfated Heparin (ODSH) in Septic Peritonitis
by: Katie D. Mauro, et al.
Published: (2022-04-01)

Thrombophilia and Recurrent Pregnancy Loss : Is heparin still the drug of choice?
by: Adel Abu-Heija
Published: (2014-02-01)

Heparin-induced thrombocytopenia and COVID-19
by: Michelangelo Sartori, et al.
Published: (2021-03-01)

Correction: Image guided dose escalated prostate radiotherapy: still room to improve
by: Milosevic Michael, et al.
Published: (2009-12-01)

To scavenge or not to scavenge, that is STILL the question.
by: Allan, E, et al.
Published: (2013)

TB or not TB: that is still the question
by: Ashfaq Hasan
Published: (2013-08-01)

COVID-19, the escalation of diabetes mellitus and the repercussions on tuberculosis
by: Pei Min Thong, et al.
Published: (2023-05-01)

That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
by: Matthew R. Davis, et al.
Published: (2020-07-01)

Applications of rotational thromboelastometry in heparin monitoring in critical COVID-19 disease: Observations in the Maastricht Intensive Care COVID cohort
by: Lejan Schultinge, et al.
Published: (2023-08-01)

High Flow Nasal Cannula in Pediatric Intensive Care Unit: Still an Open Question [Letter]
by: Alhamad BR, et al.
Published: (2021-11-01)

Neurocysticercosis: still some unanswered questions
by: Luís dos Ramos Machado
Published: (2014-05-01)

Unquestioned supremacy still begs the question
by: Marcin Baranski, et al.

The Role of Thromboelastography in Heparin Therapy for COVID-19 Patients
by: Yosua Butar Butar, et al.
Published: (2022-05-01)

Nebulized Heparin for Post-COVID-19-Related Hypoxia
by: Mehmet Hursitoglu, et al.
Published: (2021-07-01)

Escalation vs. Early Intense Therapy in Multiple Sclerosis
by: Bonaventura Casanova, et al.
Published: (2022-01-01)

To instill or not to instill â€“ is it still a question
by: Brenda Morrow
Published: (2014-07-01)

Methotrexate in pregnancy: still many unanswered questions
by: Corinna Weber-Schoendorfer, et al.
Published: (2023-03-01)

MONETARY POLICY: MANY QUESTIONS STILL REMAIN
by: M. V. Yershov
Published: (2017-10-01)

Effects of Duration of Heparin Injection on Site-Pain Intensity
by: Banafshe Tehrani Neshat, et al.
Published: (2005-03-01)

Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19
by: Lawler, PR, et al.
Published: (2021)

Therapeutic anticoagulation with heparin in critically ill patients with Covid-19
by: Goligher, EC, et al.
Published: (2021)

Low molecular weight heparin in COVID-19: benefits and concerns
by: Adham Makarem, et al.
Published: (2023-04-01)

The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
by: Jori E. May, et al.
Published: (2020-08-01)

Heparin mimetics as potential intervention for COVID-19 and their bio-manufacturing
by: Lan Jiang, et al.
Published: (2023-03-01)

Does COVID-19 escalate aging process? A possible concern
by: Katayoun Tayeri, et al.
Published: (2022-01-01)

Real de-escalation or escalation in disguise?
by: Maggie Banys-Paluchowski, et al.
Published: (2023-06-01)

Aspirin or low-molecular weight heparin for thromboprophylaxis after a fracture? That is the question
by: Giuseppe Camporese, et al.
Published: (2023-05-01)

Aspirin or low-molecular weight heparin for thromboprophylaxis after a fracture? That is the question
by: Giuseppe Camporese, et al.
Published: (2023-05-01)

Hashimoto Encephalopathy—Still More Questions than Answers
by: Marta Waliszewska-Prosół, et al.
Published: (2022-09-01)

Shout and listening at city of crazies: Still are questioning us?
by: Tania Mara Galli Fonseca
Published: (2014-12-01)

Testosterone Therapy for Women: Still Many Questions to be Answered
by: Cristina Laguna Benetti-Pinto
Published: (2022-02-01)

Dealing with Free Will in Contemporary Theology: is It Still a Question?
by: Oviedo Lluis
Published: (2019-02-01)

Opening the strands of replication origins – still an open question
by: Dhruba Chattoraj
Published: (2016-09-01)

How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation
by: Antoine Barocas, et al.
Published: (2023-09-01)

The Role of Heparin in COVID-19: An Update after Two Years of Pandemics
by: Marco Mangiafico, et al.
Published: (2022-05-01)

Continuation of therapeutic dose heparin for critically ill patients with COVID-19
by: Bradbury, CA, et al.
Published: (2023)

COVID-19 Vaccination-Associated Spontaneous Heparin-Induced Thrombocytopenia Syndrome
by: Prakash Vishnu, et al.
Published: (2023-10-01)

Randomized trials of therapeutic heparin for COVID‐19: A meta‐analysis
by: Michelle Sholzberg, et al.
Published: (2021-12-01)

Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
by: Richard R. Riker, et al.
Published: (2020-08-01)

Is there a rationale for heparin use among severe COVID-19 patients?
by: Felicio Savioli